CDC: Update on Noncongenital Zika Cases in the U.S.
Ninety-five percent of cases were identified in travelers returning from Zika virus-affected areas
Ninety-five percent of cases were identified in travelers returning from Zika virus-affected areas
A total of 240 individuals between the ages 18 and 49 are enrolled in the Phase 1 trial of TAK-426.
Sofosbuvir protected and rescued neural cells infected by the Zika virus in cell cultures and mouse models, and blocked transmission of the virus to mouse fetuses.
Not designed to diagnose the infection, however
Virus strains came from the Caribbean and Latin America, researchers say
CDC report also says too few infants are tested for the virus
Studies found greater prevalence than believed, more neurological problems appearing months after birth
Brazilian baby developed condition after being exposed to virus in womb
But it’s unclear whether simply touching these surfaces might transmit the virus, researchers say